Sulforaphene, a CDK5 inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer’s disease via reducing Aβ deposition, tau hyperphosphorylation and synaptic dysfunction - Yang, W; Xu, Q Q; Yuan, Q (Int Immunopharmacol, 2023)